These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34100394)

  • 21. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea.
    Aranda JV; Cook CE; Gorman W; Collinge JM; Loughnan PM; Outerbridge EW; Aldridge A; Neims AH
    J Pediatr; 1979 Apr; 94(4):663-8. PubMed ID: 430317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine preserves quiet sleep in preterm neonates.
    Koch G; Schönfeld N; Jost K; Atkinson A; Schulzke SM; Pfister M; Datta AN
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00596. PubMed ID: 32412185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stopping caffeine in premature neonates: how long does it take for the level of caffeine to fall below the therapeutic range?
    Chung J; Tran Lopez K; Amendolia B; Bhat V; Nakhla T; Slater-Myer L; Saslow J; Aghai ZH
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):551-555. PubMed ID: 32079435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline or caffeine: which is best for apnea of prematurity?
    Gannon BA
    Neonatal Netw; 2000 Dec; 19(8):33-6. PubMed ID: 11949272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine metabolism in premature infants.
    al-Alaiyan S; al-Rawithi S; Raines D; Yusuf A; Legayada E; Shoukri MM; el-Yazigi A
    J Clin Pharmacol; 2001 Jun; 41(6):620-7. PubMed ID: 11402630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic study of monohydrated caffeine in the treatment of apnoea of premature infant].
    Cherif A; Marrakchi Z; Klouz A; Chaouachi S; Belkahia C; Boukef-Larguèche S
    Arch Pediatr; 2003 Jun; 10(6):517-20. PubMed ID: 12915014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualizing aminophylline doses in premature infants using bioelectrical impedance: a non-invasive approach.
    Sidhu J; Triggs E; Charles B; Tudehope D; Gray P; Cowley D
    J Paediatr Child Health; 1993 Apr; 29(2):113-8. PubMed ID: 8489790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hemodynamic effects of methylxanthine therapy in preterm neonates: Effect of variations in subgroups.
    M S; Nayak K; Lewis LES; Kamath A; Purkayastha J
    J Trop Pediatr; 2019 Jun; 65(3):264-272. PubMed ID: 30085175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic aspects of caffeine in premature infants with apnoea.
    Gorodischer R; Karplus M
    Eur J Clin Pharmacol; 1982; 22(1):47-52. PubMed ID: 7094974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine citrate for apnea of prematurity-One dose does not fit all a prospective study.
    Rosen C; Taran C; Hanna M; Gueta I; Loebstein R; Strauss T; Yarden-Bilavsky H
    J Perinatol; 2021 Sep; 41(9):2292-2297. PubMed ID: 34290376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative Study of the Efficacy and Safety of Caffeine and Aminophylline for the Treatment of Apnea in Preterm Infants].
    Nagasato A; Nakamura M; Kamimura H
    Yakugaku Zasshi; 2018; 138(2):237-242. PubMed ID: 29386437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.
    Alhersh E; Abushanab D; Al-Shaibi S; Al-Badriyeh D
    Paediatr Drugs; 2020 Aug; 22(4):399-408. PubMed ID: 32488731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of formula feeding on oral absorption of caffeine in premature infants.
    Giacoia GP; Jungbluth GL; Jusko WJ
    Dev Pharmacol Ther; 1989; 12(4):205-10. PubMed ID: 2766923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental changes of caffeine elimination in infancy.
    Pons G; Carrier O; Richard MO; Rey E; d'Athis P; Moran C; Badoual J; Olive G
    Dev Pharmacol Ther; 1988; 11(5):258-64. PubMed ID: 3191817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants.
    Murat I; Moriette G; Blin MC; Couchard M; Flouvat B; De Gamarra E; Relier JP; Dreyfus-Brisac C
    J Pediatr; 1981 Dec; 99(6):984-9. PubMed ID: 7310594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of caffeine in premature neonates.
    Falcão AC; Fernández de Gatta MM; Delgado Iribarnegaray MF; Santos Buelga D; García MJ; Dominguez-Gil A; Lanao JM
    Eur J Clin Pharmacol; 1997; 52(3):211-7. PubMed ID: 9218928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of theophylline to caffeine in premature newborn infants.
    Bory C; Baltassat P; Porthault M; Bethenod M; Frederich A; Aranda JV
    J Pediatr; 1979 Jun; 94(6):988-93. PubMed ID: 448554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.